Acute promyelocytic leukemia in children

Area of Science:

• Pediatric Hematology Oncology
• Hematologic Malignancies
• Leukemia Research

Background:

• Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia.
• Childhood APL shares characteristics with adult APL but may have unique clinical features.

Purpose of the Study:

• To retrospectively analyze the clinical features, treatment, and outcomes of pediatric patients with acute promyelocytic leukemia.
• To identify specific challenges in childhood APL, including extramedullary manifestations and mortality.

Main Methods:

• Retrospective chart review of 16 children (ages 2-17) diagnosed with APL.
• Diagnosis based on FAB classification morphological criteria.
• Analysis of presenting symptoms, laboratory findings, treatment regimens, and patient outcomes.

Main Results:

• Bleeding diathesis and disseminated intravascular coagulation (DIC) were predominant presenting symptoms (>85%).
• Extramedullary manifestations occurred in 6 patients (skin rash, gum infiltration, meningeal leukemia).
• 37.5% of patients did not achieve remission and died from hemorrhage or infection; median remission duration was 14 months.

Conclusions:

• Childhood APL exhibits a high frequency of extramedullary manifestations and significant mortality, particularly from neutropenia.
• Treatment strategies require optimization to improve remission rates and survival in pediatric APL.
• Further investigation into specific pediatric APL characteristics is warranted.